Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
Authors
Keywords
-
Journal
Nutrients
Volume 5, Issue 3, Pages 928-948
Publisher
MDPI AG
Online
2013-03-19
DOI
10.3390/nu5030928
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans
- (2013) Surabhi Bhutani et al. Obesity
- Drug Treatment of Obesity in Cardiovascular Disease
- (2012) Marietta Charakida et al. American Journal of Cardiovascular Drugs
- Do we need anti-obesity drugs?
- (2012) Vojtěch Hainer et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
- (2012) Ioanna Gouni-Berthold et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome
- (2012) A. P. Agouridis et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- High-density lipoprotein subclasses and their relationship to cardiovascular disease
- (2012) H. Robert Superko et al. Journal of Clinical Lipidology
- Extended-Release Niacin/Laropiprant Effects on Lipoprotein Subfractions in Patients with Type 2 Diabetes Mellitus
- (2012) Harold Bays et al. Metabolic Syndrome and Related Disorders
- Effect of Anti-Obesity Drug on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2012) Yu-Hao Zhou et al. PLoS One
- Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
- (2012) Aneta Otocka-Kmiecik et al. PROGRESS IN LIPID RESEARCH
- The Effect of Exercise on the Cardiovascular Risk Factors Constituting the Metabolic Syndrome
- (2012) Nele Pattyn et al. SPORTS MEDICINE
- Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol
- (2012) Kaori Hosoyamada et al. Diabetology & Metabolic Syndrome
- Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: ‘A new kid on the block’?
- (2011) Niki Katsiki et al. ANNALS OF MEDICINE
- Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk1
- (2011) Manfredi Rizzo et al. CLINICAL ENDOCRINOLOGY
- Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size
- (2011) Hideo Makimura et al. CLINICAL ENDOCRINOLOGY
- Metabolic and functional relevance of HDL subspecies
- (2011) Bela F Asztalos et al. CURRENT OPINION IN LIPIDOLOGY
- Editorial [Hot Topic: New Developments in the Prevention and Treatment of Vascular Disease - 2 Executive (Guest Editors: Manfredi Rizzo and Dimitri P. Mikhailidis)]
- (2011) Manfredi Rizzo et al. CURRENT PHARMACEUTICAL DESIGN
- Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
- (2011) Alexandros D. Tselepis et al. CURRENT PHARMACEUTICAL DESIGN
- Definition of Postprandial Lipaemia
- (2011) Genovefa D. Kolovou et al. Current Vascular Pharmacology
- Diagnostic Value of Postprandial Triglyceride Testing in Healthy Subjects:A Meta-Analysis
- (2011) Constantinos Mihas et al. Current Vascular Pharmacology
- “European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
- (2011) Dimitri P. Mikhailidis et al. Current Vascular Pharmacology
- “European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
- (2011) Dimitri P. Mikhailidis et al. Current Vascular Pharmacology
- Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
- (2011) Genovefa D. Kolovou et al. Current Vascular Pharmacology
- Fenofibrate
- (2011) Kate McKeage et al. DRUGS
- Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?
- (2011) Manfredi Rizzo et al. EXPERT OPINION ON PHARMACOTHERAPY
- Low-Density Lipoprotein Sub-Fraction Profiles in Obese Children Before and After Attending a Residential Weight Loss Intervention
- (2011) Roderick FGJ King et al. Journal of Atherosclerosis and Thrombosis
- Small LDL-Cholesterol is Superior to LDL-Cholesterol for Determining Severe Coronary Atherosclerosis
- (2011) Shinji Koba et al. Journal of Atherosclerosis and Thrombosis
- Effects of Atorvastatin on Nuclear Magnetic Resonance-Defined Lipoprotein Subclasses and Inflammatory Markers in Patients with Hypercholesterolemia
- (2011) Katsunori Ikewaki et al. Journal of Atherosclerosis and Thrombosis
- Influence of Fatty Liver on Plasma Small, Dense LDL- Cholesterol in Subjects with and without Metabolic Syndrome
- (2011) Ikumi Sugino et al. Journal of Atherosclerosis and Thrombosis
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia
- (2011) Christie Ballantyne et al. Journal of Clinical Lipidology
- Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome
- (2011) Y K Kim et al. JOURNAL OF HUMAN HYPERTENSION
- Pro-atherogenic postprandial profile: Meal-induced changes of lipoprotein sub-fractions and inflammation markers in obese boys
- (2011) C. Maffeis et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Cardiovascular benefits of bariatric surgery in morbidly obese patients
- (2011) V. G. Athyros et al. Obesity Reviews
- Evolution of Lipid Profiles after Bariatric Surgery
- (2011) Ignacio Garcia-Marirrodriga et al. OBESITY SURGERY
- Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases
- (2011) Hana Rosolova et al. EPMA Journal
- Effects of Rosiglitazone on Fasting and Postprandial Low- and High-Density Lipoproteins Size and Subclasses in Type 2 Diabetes
- (2010) Manfredi Rizzo et al. ANGIOLOGY
- Improvements in LDL particle size and distribution by short-term alternate day modified fasting in obese adults
- (2010) Krista A. Varady et al. BRITISH JOURNAL OF NUTRITION
- Lipoprotein subfractions and cardiovascular disease risk
- (2010) Ronald M Krauss CURRENT OPINION IN LIPIDOLOGY
- High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?
- (2010) Laura Calabresi et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia
- (2010) Matilda Florentin et al. Current Vascular Pharmacology
- Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure
- (2010) Corby K. Martin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of a reduced carbohydrate and reduced fat diet for LDL, HDL, and VLDL subclasses during 9-months of weight maintenance subsequent to weight loss
- (2010) James D LeCheminant et al. Lipids in Health and Disease
- Ethnic differences in serum lipoproteins and their determinants in South African women
- (2010) Julia H. Goedecke et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The effect of ınsulin resistance and obesity on low-density lipoprotein particle size in children
- (2010) Mehmet Emre Taşçılar Journal of Clinical Research in Pediatric Endocrinology
- Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults
- (2009) Krista A Varady et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- LDL and HDL subclasses in acute ischemic stroke: Prediction of risk and short-term mortality
- (2009) Aleksandra Zeljkovic et al. ATHEROSCLEROSIS
- Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
- (2009) Vasilios Athyros et al. CURRENT DRUG TARGETS
- Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype
- (2009) M. Rizzo et al. HUMAN REPRODUCTION
- Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
- (2009) Kimber L. Stanhope et al. JOURNAL OF CLINICAL INVESTIGATION
- Drug-induced fibrotic valvular heart disease
- (2009) Sanjeev Bhattacharyya et al. LANCET
- Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity
- (2009) M.B. Bos et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Reversal of Small, Dense LDL Subclass Phenotype by Normalization of Adiposity
- (2009) Patty W. Siri-Tarino et al. Obesity
- Atherogenic dyslipidemia and oxidative stress: a new look
- (2009) Manfredi Rizzo et al. Translational Research
- Effect of Combination Nicotinic Acid and Gemfibrozil Treatment on Intermediate Density Lipoprotein, and Subclasses of Low Density Lipoprotein and High Density Lipoprotein in Patients With Combined Hyperlipidemia
- (2008) H. Robert Superko et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of Rimonabant on the High-Triglyceride/ Low–HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat
- (2008) Jean-Pierre Després et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Small Dense LDL-Cholesterol Relative to LDL-Cholesterol is a Strong Independent Determinant of Hypoadiponectinemia in Metabolic Syndrome
- (2008) Noriko Satoh et al. CIRCULATION JOURNAL
- Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome
- (2008) Manfredi Rizzo et al. CLINICAL ENDOCRINOLOGY
- Is it LDL particle size or number that correlates with risk for cardiovascular disease?
- (2008) H. Robert Superko et al. Current Atherosclerosis Reports
- The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia
- (2008) E. S. Nakou et al. CURRENT MEDICAL RESEARCH AND OPINION
- Multiple actions of high-density lipoprotein
- (2008) Matilda Florentin et al. CURRENT OPINION IN CARDIOLOGY
- Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes
- (2008) M. Rizzo et al. DIABETIC MEDICINE
- The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia
- (2008) ES Nakou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes
- (2008) Kaspar Berneis et al. EXPERT OPINION ON PHARMACOTHERAPY
- LDL size and subclasses in patients with abdominal aortic aneurysm
- (2008) Manfredi Rizzo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome
- (2008) K. Berneis et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women
- (2008) F Magkos et al. INTERNATIONAL JOURNAL OF OBESITY
- Lipoprotein Management in Patients With Cardiometabolic Risk
- (2008) John D. Brunzell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic Syndrome
- (2008) K. G. Lagos et al. LIPIDS
- Bariatric Surgery Improves Atherogenic LDL Profile by Triglyceride Reduction
- (2008) Sabina Zambon et al. OBESITY SURGERY
- Hypertension and dyslipidaemia in obesity and insulin resistance: Pathophysiology, impact on atherosclerotic disease and pharmacotherapy
- (2008) M. John Chapman et al. PHARMACOLOGY & THERAPEUTICS
- Comparison of the effects of four commercially available weight-loss programmes on lipid-based cardiovascular risk factors
- (2008) LM Morgan et al. PUBLIC HEALTH NUTRITION
- Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity
- (2007) Juliana A. de Souza et al. ATHEROSCLEROSIS
- Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease
- (2007) Manfredi Rizzo et al. ATHEROSCLEROSIS
- The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome
- (2007) T. D. Filippatos et al. DIABETES OBESITY & METABOLISM
- Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women
- (2007) T. Tzotzas et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started